Evaluating the Sensitivity of to Biotin Deprivation Using Regulated Gene Expression

English version České info

In the search for new drug targets, we evaluated the biotin synthetic pathway of Mycobacterium tuberculosis (Mtb) and constructed an Mtb mutant lacking the biotin biosynthetic enzyme 7,8-diaminopelargonic acid synthase, BioA. In biotin-free synthetic media, ΔbioA did not produce wild-type levels of biotinylated proteins, and therefore did not grow and lost viability. ΔbioA was also unable to establish infection in mice. Conditionally-regulated knockdown strains of Mtb similarly exhibited impaired bacterial growth and viability in vitro and in mice, irrespective of the timing of transcriptional silencing. Biochemical studies further showed that BioA activity has to be reduced by approximately 99% to prevent growth. These studies thus establish that de novo biotin synthesis is essential for Mtb to establish and maintain a chronic infection in a murine model of TB. Moreover, these studies provide an experimental strategy to systematically rank the in vivo value of potential drug targets in Mtb and other pathogens.

Vyšlo v časopise: Evaluating the Sensitivity of to Biotin Deprivation Using Regulated Gene Expression. PLoS Pathog 7(9): e32767. doi:10.1371/journal.ppat.1002264
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002264

Souhrn

Zdroje

1. DyeCWilliamsBG 2010 The population dynamics and control of tuberculosis. Science 328 856 861

2. LoBueP 2009 Extensively drug-resistant tuberculosis. Curr Opin Infect Dis 22 167 173

3. HoffmannCLeisANiederweisMPlitzkoJMEngelhardtH 2008 Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc Natl Acad Sci U S A 105 3963 3967

4. ZuberBChamiMHoussinCDubochetJGriffithsG 2008 Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J Bacteriol 190 5672 5680

5. SaniMHoubenENGeurtsenJPiersonJde PunderK 2010 Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLoS Pathog 6 e1000794

6. DanielJOhTJLeeCMKolattukudyPE 2007 AccD6, a member of the Fas II locus, is a functional carboxyltransferase subunit of the acyl-coenzyme A carboxylase in Mycobacterium tuberculosis. J Bacteriol 189 911 917

7. GagoGKurthDDiacovichLTsaiSCGramajoH 2006 Biochemical and structural characterization of an essential acyl coenzyme A carboxylase from Mycobacterium tuberculosis. J Bacteriol 188 477 486

8. KurthDGGagoGMde la IglesiaABazet LyonnetBLinTW 2009 ACCase 6 is the essential acetyl-CoA carboxylase involved in fatty acid and mycolic acid biosynthesis in mycobacteria. Microbiology 155 2664 2675

9. OhTJDanielJKimHJSirakovaTDKolattukudyPE 2006 Identification and characterization of Rv3281 as a novel subunit of a biotin-dependent acyl-CoA Carboxylase in Mycobacterium tuberculosis H37Rv. J Biol Chem 281 3899 3908

10. Massengo-TiasséRCronanJ 2009 Diversity in enoyl-acyl carrier protein reductases. Cell Mol Life Sci 66 1507 1517

11. DeySLaneJMLeeRERubinEJSacchettiniJC 2010 Structural characterization of the Mycobacterium tuberculosis biotin biosynthesis enzymes 7,8-diaminopelargonic acid synthase and dethiobiotin synthetase. Biochemistry 49 6746 6760

12. PurushothamanSGuptaGSrivastavaRRamuVGSuroliaA 2008 Ligand specificity of group I biotin protein ligase of Mycobacterium tuberculosis. PLoS One 3 e2320

13. YuJNiuCWangDLiMTeoW 2011 MMAR_2770, a new enzyme involved in biotin biosynthesis, is essential for the growth of Mycobacterium marinum in macrophages and zebrafish. Microbes Infect 13 33 41

14. OkamiYKitaharaTHamadaMNaganawaHKondoS 1974 Studies on a new amino acid antibiotic, amiclenomycin. J Antibiot (Tokyo) 27 656 664

15. MannSPlouxO 2006 7,8-Diaminoperlargonic acid aminotransferase from Mycobacterium tuberculosis, a potential therapeutic target. Characterization and inhibition studies. FEBS J 273 4778 4789

16. KitaharaTHottaKYoshidaMOkamiY 1975 Biological studies of amiclenomycin. J Antibiot (Tokyo) 28 215 221

17. SassettiCMRubinEJ 2003 Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A 100 12989 12994

18. RheeKYErdjument-BromageHTempstPNathanCF 2005 S-nitroso proteome of Mycobacterium tuberculosis: Enzymes of intermediary metabolism and antioxidant defense. Proc Natl Acad Sci U S A 102 467 472

19. EhrtSGuoXVHickeyCMRyouMMonteleoneM 2005 Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res 33 e21

20. KlotzscheMEhrtSSchnappingerD 2009 Improved tetracycline repressors for gene silencing in mycobacteria. Nucleic Acids Res 37 1778 1788

21. HayakawaKOizumiJ 1987 Determination of free biotin in plasma by liquid chromatography with fluorimetric detection. J Chromatogr 413 247 250

22. HartheCClaustratB 2003 A sensitive and practical competitive radioassay for plasma biotin. Ann Clin Biochem 40 259 263

23. KeerJSmeuldersMJGrayKMWilliamsHD 2000 Mutants of Mycobacterium smegmatis impaired in stationary-phase survival. Microbiology 146 Pt 9 2209 2217

24. BoshoffHIDartoisVDickTEhrtS 2009 The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7 845 855

25. KimJHWeiJRWallachJBRobbinsRSRubinEJ 2010 Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase. Nucleic Acids Res 39 2210 2220

26. WeiJRKrishnamoorthyVMurphyKKimJHSchnappingerD 2011 Depletion of antibiotic targets has widely varying effects on growth. Proc Natl Acad Sci U S A 108 4176 4181

27. MannSLesageDTabetJ-CMarquetA 2003 Identification of the products of reaction between pyridoxal phosphate and amiclenomycin and other related 1-amino-cyclohexa-2,5-dienes. Tetrahedron 59 5209 5214

28. LuHTongePJ 2010 Drug-target residence time: critical information for lead optimization. Curr Opin Chem Biol 14 467 474

29. PayneDJGwynnMNHolmesDJPomplianoDL 2007 Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6 29 40

30. BardarovSKriakovJCarriereCYuSVaamondeC 1997 Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 94 10961 10966

31. BardarovSBardarovJrSJrPavelkaJrMSJrSambandamurthyVLarsenM 2002 Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148 3007 3017

32. BlumenthalATrujilloCEhrtSSchnappingerD 2010 Simultaneous analysis of multiple Mycobacterium tuberculosis knockdown mutants in vitro and in vivo. PLoS One 5 e15667

33. ShiSEhrtS 2006 Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis. Infect Immun 74 56 63

34. WilsonDJShiCDuckworthBPMurettaJMManjunathaU 2011 A continuous fluorescence displacement assay for BioA: An enzyme involved in biotin biosynthesis. Anal Biochem 416 27 38

35. GandotraSSchnappingerDMonteleoneMHillenWEhrtS 2007 In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice. Nat Med 13 1515 1520